Chang, T.;                     Ho, H.-L.;                     Hsu, S.-J.;                     Chang, C.-C.;                     Tsai, M.-H.;                     Huo, T.-I.;                     Huang, H.-C.;                     Lee, F.-Y.;                     Hou, M.-C.;                     Lee, S.-D.    
        Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats. Int. J. Mol. Sci. 2019, 20, 4161.
    https://doi.org/10.3390/ijms20174161
    AMA Style
    
                                Chang T,                                 Ho H-L,                                 Hsu S-J,                                 Chang C-C,                                 Tsai M-H,                                 Huo T-I,                                 Huang H-C,                                 Lee F-Y,                                 Hou M-C,                                 Lee S-D.        
                Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats. International Journal of Molecular Sciences. 2019; 20(17):4161.
        https://doi.org/10.3390/ijms20174161
    
    Chicago/Turabian Style
    
                                Chang, Ting,                                 Hsin-Ling Ho,                                 Shao-Jung Hsu,                                 Ching-Chih Chang,                                 Ming-Hung Tsai,                                 Teh-Ia Huo,                                 Hui-Chun Huang,                                 Fa-Yauh Lee,                                 Ming-Chih Hou,                                 and Shou-Dong Lee.        
                2019. "Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats" International Journal of Molecular Sciences 20, no. 17: 4161.
        https://doi.org/10.3390/ijms20174161
    
    APA Style
    
                                Chang, T.,                                 Ho, H.-L.,                                 Hsu, S.-J.,                                 Chang, C.-C.,                                 Tsai, M.-H.,                                 Huo, T.-I.,                                 Huang, H.-C.,                                 Lee, F.-Y.,                                 Hou, M.-C.,                                 & Lee, S.-D.        
        
        (2019). Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats. International Journal of Molecular Sciences, 20(17), 4161.
        https://doi.org/10.3390/ijms20174161